Tuberculosis Vaccines Market Report

Global Tuberculosis Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：177
  • REPORT CODE：GMM826882
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Tuberculosis Vaccines market report explains the definition, types, applications, major countries, and major players of the Tuberculosis Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Japan BCG Lab

    • Bavarian Nordic

    • GlaxoSmithKline

    • Sanofi

    • Merck

    • Taj Pharmaceuticals

    • IDT Biologics

    • China National Biotec Group

    • GreenSignal Bio Pharma

    • Serum Institute of India

    By Type:

    • Immunotherapeutic Vaccines

    • Booster Vaccines

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Tuberculosis Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Tuberculosis Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Tuberculosis Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Tuberculosis Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Tuberculosis Vaccines Market- Recent Developments

    • 6.1 Tuberculosis Vaccines Market News and Developments

    • 6.2 Tuberculosis Vaccines Market Deals Landscape

    7 Tuberculosis Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Tuberculosis Vaccines Key Raw Materials

    • 7.2 Tuberculosis Vaccines Price Trend of Key Raw Materials

    • 7.3 Tuberculosis Vaccines Key Suppliers of Raw Materials

    • 7.4 Tuberculosis Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Tuberculosis Vaccines Cost Structure Analysis

      • 7.5.1 Tuberculosis Vaccines Raw Materials Analysis

      • 7.5.2 Tuberculosis Vaccines Labor Cost Analysis

      • 7.5.3 Tuberculosis Vaccines Manufacturing Expenses Analysis

    8 Global Tuberculosis Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Tuberculosis Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Tuberculosis Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Tuberculosis Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Tuberculosis Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immunotherapeutic Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Booster Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Tuberculosis Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Tuberculosis Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Tuberculosis Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Tuberculosis Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Tuberculosis Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Tuberculosis Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.2 UK Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.5 France Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Tuberculosis Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Tuberculosis Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Tuberculosis Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Tuberculosis Vaccines Consumption (2017-2022)

      • 10.4.3 India Tuberculosis Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Tuberculosis Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Tuberculosis Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Tuberculosis Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Tuberculosis Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Tuberculosis Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Tuberculosis Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Tuberculosis Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Tuberculosis Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Tuberculosis Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Tuberculosis Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Tuberculosis Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Tuberculosis Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Tuberculosis Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Tuberculosis Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Tuberculosis Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Tuberculosis Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Tuberculosis Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Tuberculosis Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Tuberculosis Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Tuberculosis Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Tuberculosis Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Tuberculosis Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Tuberculosis Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Tuberculosis Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Tuberculosis Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Tuberculosis Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Tuberculosis Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Tuberculosis Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Tuberculosis Vaccines Consumption (2017-2022)

    11 Global Tuberculosis Vaccines Competitive Analysis

    • 11.1 Japan BCG Lab

      • 11.1.1 Japan BCG Lab Company Details

      • 11.1.2 Japan BCG Lab Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Japan BCG Lab Tuberculosis Vaccines Main Business and Markets Served

      • 11.1.4 Japan BCG Lab Tuberculosis Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Bavarian Nordic

      • 11.2.1 Bavarian Nordic Company Details

      • 11.2.2 Bavarian Nordic Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Bavarian Nordic Tuberculosis Vaccines Main Business and Markets Served

      • 11.2.4 Bavarian Nordic Tuberculosis Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 GlaxoSmithKline

      • 11.3.1 GlaxoSmithKline Company Details

      • 11.3.2 GlaxoSmithKline Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 GlaxoSmithKline Tuberculosis Vaccines Main Business and Markets Served

      • 11.3.4 GlaxoSmithKline Tuberculosis Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Sanofi

      • 11.4.1 Sanofi Company Details

      • 11.4.2 Sanofi Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Sanofi Tuberculosis Vaccines Main Business and Markets Served

      • 11.4.4 Sanofi Tuberculosis Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Merck

      • 11.5.1 Merck Company Details

      • 11.5.2 Merck Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Merck Tuberculosis Vaccines Main Business and Markets Served

      • 11.5.4 Merck Tuberculosis Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Taj Pharmaceuticals

      • 11.6.1 Taj Pharmaceuticals Company Details

      • 11.6.2 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Taj Pharmaceuticals Tuberculosis Vaccines Main Business and Markets Served

      • 11.6.4 Taj Pharmaceuticals Tuberculosis Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 IDT Biologics

      • 11.7.1 IDT Biologics Company Details

      • 11.7.2 IDT Biologics Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 IDT Biologics Tuberculosis Vaccines Main Business and Markets Served

      • 11.7.4 IDT Biologics Tuberculosis Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 China National Biotec Group

      • 11.8.1 China National Biotec Group Company Details

      • 11.8.2 China National Biotec Group Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 China National Biotec Group Tuberculosis Vaccines Main Business and Markets Served

      • 11.8.4 China National Biotec Group Tuberculosis Vaccines Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 GreenSignal Bio Pharma

      • 11.9.1 GreenSignal Bio Pharma Company Details

      • 11.9.2 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 GreenSignal Bio Pharma Tuberculosis Vaccines Main Business and Markets Served

      • 11.9.4 GreenSignal Bio Pharma Tuberculosis Vaccines Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Serum Institute of India

      • 11.10.1 Serum Institute of India Company Details

      • 11.10.2 Serum Institute of India Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Serum Institute of India Tuberculosis Vaccines Main Business and Markets Served

      • 11.10.4 Serum Institute of India Tuberculosis Vaccines Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Tuberculosis Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Tuberculosis Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Immunotherapeutic Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Booster Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Tuberculosis Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Tuberculosis Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Tuberculosis Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Tuberculosis Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Tuberculosis Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Tuberculosis Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Tuberculosis Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Tuberculosis Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Tuberculosis Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Tuberculosis Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Tuberculosis Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Tuberculosis Vaccines

    • Figure of Tuberculosis Vaccines Picture

    • Table Global Tuberculosis Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Tuberculosis Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Immunotherapeutic Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Booster Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Tuberculosis Vaccines Consumption by Country (2017-2022)

    • Table North America Tuberculosis Vaccines Consumption by Country (2017-2022)

    • Figure United States Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Tuberculosis Vaccines Consumption by Country (2017-2022)

    • Figure Germany Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Tuberculosis Vaccines Consumption by Country (2017-2022)

    • Figure China Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Tuberculosis Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Tuberculosis Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Tuberculosis Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Tuberculosis Vaccines Consumption by Country (2017-2022)

    • Figure Australia Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Tuberculosis Vaccines Consumption and Growth Rate (2017-2022)

    • Table Japan BCG Lab Company Details

    • Table Japan BCG Lab Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Japan BCG Lab Tuberculosis Vaccines Main Business and Markets Served

    • Table Japan BCG Lab Tuberculosis Vaccines Product Portfolio

    • Table Bavarian Nordic Company Details

    • Table Bavarian Nordic Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic Tuberculosis Vaccines Main Business and Markets Served

    • Table Bavarian Nordic Tuberculosis Vaccines Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Tuberculosis Vaccines Main Business and Markets Served

    • Table GlaxoSmithKline Tuberculosis Vaccines Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Tuberculosis Vaccines Main Business and Markets Served

    • Table Sanofi Tuberculosis Vaccines Product Portfolio

    • Table Merck Company Details

    • Table Merck Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Tuberculosis Vaccines Main Business and Markets Served

    • Table Merck Tuberculosis Vaccines Product Portfolio

    • Table Taj Pharmaceuticals Company Details

    • Table Taj Pharmaceuticals Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taj Pharmaceuticals Tuberculosis Vaccines Main Business and Markets Served

    • Table Taj Pharmaceuticals Tuberculosis Vaccines Product Portfolio

    • Table IDT Biologics Company Details

    • Table IDT Biologics Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table IDT Biologics Tuberculosis Vaccines Main Business and Markets Served

    • Table IDT Biologics Tuberculosis Vaccines Product Portfolio

    • Table China National Biotec Group Company Details

    • Table China National Biotec Group Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table China National Biotec Group Tuberculosis Vaccines Main Business and Markets Served

    • Table China National Biotec Group Tuberculosis Vaccines Product Portfolio

    • Table GreenSignal Bio Pharma Company Details

    • Table GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GreenSignal Bio Pharma Tuberculosis Vaccines Main Business and Markets Served

    • Table GreenSignal Bio Pharma Tuberculosis Vaccines Product Portfolio

    • Table Serum Institute of India Company Details

    • Table Serum Institute of India Tuberculosis Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Tuberculosis Vaccines Main Business and Markets Served

    • Table Serum Institute of India Tuberculosis Vaccines Product Portfolio

    • Figure Global Immunotherapeutic Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Booster Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tuberculosis Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Tuberculosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Tuberculosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Tuberculosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Tuberculosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Tuberculosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Tuberculosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Tuberculosis Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Tuberculosis Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US